This statement relates to content available on the Biosimilar Hub website http://188.8.131.52/~biosimil
This website has been developed with the aim to be available to the widest possible audience, including those using assistive technology or accessibility features. Ongoing monitoring and development is part of our strategy and we strive to comply with W3C’s Web Content Accessibility Guidelines.
At times, we publish documents and publications received from third parties. These third-party documents may not adhere to the standards followed by the GBMA.
If you have any questions or comments about this statement or have problems accessing information or functions on this site please contact us.